Business

Germany: VisionHealth, a digital therapeutics company focused on enhancing inhaled treatment of chronic lung diseases, has closed a €3m pre-series A financing led by...

Kazia Therapeutics, an oncology-focused drug development company, has concluded an equity financing round totalling A$7.106m (US$4.78m) split A$4.5m raised from existing sophisticated and institutional...

Two shareholders of Amvis Holdings, a fast-growing operator of hospice-type, disability nursing facilities, are selling 10 million shares to raise JPY34.2bn (US$255.1m) through a...

Teva Pharmaceutical Industries, a global leader in generic and innovative medicines, is issuing US$2.06bn (equivalent) of euro-denominated and US dollar-denominated sustainability-linked notes. Teva is...

Digital health and med-tech investment firm Spex Capital has launched a new fund with a target size of €100m. The Spex Venture HealthTech Fund is a closed-end...

UK-headquartered Anglo-Swedish global biopharmaceutical company, AstraZeneca, has issued €1.5bn (US$1.6bn) in fixed-rate bonds split between two equally sized tranches over four and nine years. The...

Milan-based dedicated life science VC, Panakès Partners, has announced the final close of its Purple Fund at a total of €175m (US$186m). Panakès Purple...

France: Previa Medical, a deeptech start-up developing predictive medical devices for alerting healthcare providers to the risk of potential complications, has raised €2.1m (US$2.2m)...

Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, has closed an oversubscribed US$135m Series B financing....

NZX-listed Ryman Healthcare, which owns and operates 45 retirement villages in New Zealand and Australia, has completed the institutional component (Institutional Entitlement Offer) of...